Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 10 - 12 save search
CytoSorbents Receives Full FDA Investigational Device Exemption (IDE) Approval to Begin U.S. STAR-D Trial on Apixaban and Rivaroxaban Removal by the DrugSorb-ATR™ Antithrombotic Removal System During Urgent Cardiothoracic Surgery
Published: 2021-10-12 (Crawled : 23:00) - cytosorbents.com
CTSO | $0.8217 -6.52% -7.06% 2.5K
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: -10.38%
fda drug device iot cardio trial approval
Industrial Robot Sensors Market to grow by USD 1.50 Bn from 2021 to 2025| Miniaturization of Sensors to Boost Growth| 17000+ Technavio Reports
Published: 2021-10-12 (Crawled : 22:00) - prnewswire.com
SEKEY | $9.02 0.78% -1.89% 31K
|
Manufacturing
|
| O: -1.03%
H: 0.0%
C: -0.42%
HON | News 4 | $194.79 -0.7% -0.74% 2.3M
|
Producer Manufacturing
|
| O: 0.45%
H: 0.65%
C: 0.13%
sensor growth trial
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual Meeting
Published: 2021-10-12 (Crawled : 20:00) - globenewswire.com
EYPT | News | $16.47 -6.26% -6.68% 820K
|
Health Technology
|
| O: -0.18%
H: 1.9%
C: 0.19%
eye phase 1 retina trial
Cisco Lauded by Frost & Sullivan for Supporting Industrial IoT Deployments with Its Leading Portfolio of Secure and Scalable Solutions
Published: 2021-10-12 (Crawled : 17:00) - prnewswire.com
CSCO | News | $48.35 0.06% 0.02% 22K
|
Technology Services
|
| O: 0.11%
H: 0.13%
C: -1.29%
iot trial
Industrial Robots Market in Automotive Industry to grow by USD 3.97 Bn | APAC to Occupy 67% Market Share | Technavio
Published: 2021-10-12 (Crawled : 14:15) - prnewswire.com
ABLZF | News | $49.574 2.46% -32.74% 0
|
Producer Manufacturing
|
| O: -1.97%
H: 0.78%
C: -1.62%
SEKEY | $9.02 0.78% -1.89% 31K
|
Manufacturing
|
| O: 0.05%
H: 0.0%
C: -0.51%
DNZOY | $18.14 -0.77% 0.08% 0
|
Manufacturing
|
| O: -0.24%
H: 0.6%
C: 0.15%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 1.87%
H: 0.03%
C: -0.54%
automotive trial
Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients
Published: 2021-10-12 (Crawled : 14:00) - ir.hoththerapeutics.com
HOTH | $1.17 -1.68% 1.2% 17K
|
Health Technology
|
| O: 0.0%
H: 12.17%
C: 0.87%
treatment dermatitis trial approval atopic dermatitis xin
Ballard to Power Talgo Fuel Cell Passenger Train in European Trial, Ahead of Planned 2023 Launch
Published: 2021-10-12 (Crawled : 13:15) - prnewswire.com
BLDP | $2.59 -1.52% -1.54% 3.4M
|
Producer Manufacturing
|
| O: 1.09%
H: 7.84%
C: 7.4%
europe trial fuel cell train
CSW Industrials Declares Quarterly Dividend
Published: 2021-10-12 (Crawled : 13:00) - globenewswire.com
CSWI | $237.8358 -0.59% -0.55% 37K
|
Process Industries
|
| O: 0.83%
H: 0.0%
C: -0.82%
trials trial
EMCORE Introduces New SDC500 MEMS Inertial Measurement Unit for Commercial and Industrial Applications
Published: 2021-10-12 (Crawled : 13:00) - globenewswire.com
EMKR 4 | $2.95 3.51% 3.06% 190K
|
Electronic Technology
|
| O: -0.14%
H: 0.98%
C: 0.84%
trial application commercialization
Seagen and Astellas Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) With Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Published: 2021-10-12 (Crawled : 13:00) - biospace.com/
ALPMY | News | $9.47 -0.21% -1.11% 20K
|
Manufacturing
|
| O: 2.57%
H: 0.0%
C: -2.82%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.22%
H: 2.27%
C: 1.35%
treatment cancer trial enroll
Astellas and Seagen Complete Enrollment in EV-103 Trial Cohort K Combining PADCEV® (enfortumab vedotin-ejfv) with Pembrolizumab as First-Line Treatment for Advanced Urothelial Cancer
Published: 2021-10-12 (Crawled : 12:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 20K
|
Manufacturing
|
| O: 2.57%
H: 0.0%
C: -2.82%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.22%
H: 2.27%
C: 1.35%
treatment cancer trial enroll
Otonomy Announces Publication of Phase 1/2 Trial Results Showing Tinnitus Improvement in Patients Receiving OTO-313
Published: 2021-10-12 (Crawled : 12:00) - globenewswire.com
OTIC | $0.077
|
Health Technology
|
| O: 0.0%
H: 3.45%
C: 0.0%
phase 1 results trial trial results phase 2
Aerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in Japan
Published: 2021-10-12 (Crawled : 12:00) - biospace.com/
AERI | $15.25 0.0%
|
Health Technology
|
| O: 1.07%
H: 3.87%
C: 0.68%
positive results topline phase 3 trial
Industrial Media Converters Market to grow by USD 67.32 million from 2021 to 2025| Advantech Co. Ltd. and Aegis Logistics Ltd. among Key Vendors|Technavio
Published: 2021-10-12 (Crawled : 09:00) - prnewswire.com
BDC | $83.25 -1.16% 0.0% 280K
|
Producer Manufacturing
|
| O: 0.03%
H: 0.61%
C: -0.49%
media trial
PARRIS Law Firm Obtains $10.6 Million Verdict in Wrongful Death Trial
Published: 2021-10-11 (Crawled : 02:00) - prnewswire.com
SRE | $72.04 0.73% 0.0% 2.4M
|
Utilities
|
| O: 0.45%
H: 0.89%
C: 0.59%
trial
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 17M
|
TSLA | News | $162.13 12.06% 10.13% 170M
|
Consumer Durables
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.